Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
The Lancet Gastroenterology & Hepatology in conversation with - Un podcast de The Lancet Group
Catégories:
Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection. Read the full article: Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljour...
